Product Information
TELMISARTAN 80 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1633 per EA under NDC 65862086903. Its NADAC has been published 542 times since May 18, 2016.
FDA first approved this application on Sep 3, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862086903
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA206511FDA Approved
9/3/2015
TE Code
AB
On Market Since
9/3/2015
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 80 MG TABLET has been published 542 times since May 18, 2016, and over the history we have for it it has declined 68.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1633 per EA |
|---|---|
| All-time high | $0.6664 (Mar 11, 2020) |
| All-time low | $0.1345 (May 22, 2024) |
| 52-week high | $0.1633 |
| 52-week low | $0.1473 |
| Median price | $0.3491 |
| Average price | $0.3349 |
| Largest weekly change | +53.7% (Nov 22, 2023) |
| Weeks tracked | 542 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Telmisartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TELMISARTAN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1633 per EA (NDC 65862086903), effective Sep 30, 2026.
How has the price of TELMISARTAN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 68.1%. It has been tracked across 542 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?
Since May 18, 2016, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.1345 (May 22, 2024) to a high of $0.6664 (Mar 11, 2020), with a median of $0.3491 per EA.
Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 80 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN 80 MG TABLET?
TELMISARTAN 80 MG TABLET (NDC 65862086903) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.